Combining 1H-NMR-based metabonomics and network pharmacology to dissect the mechanism of antidepression effect of Milletia speciosa Champ on mouse with chronic unpredictable mild stress-induced depression

Author:

Su Zhiheng1ORCID,Ruan Junxiang12,Liu Xi1,Zheng Hua3,Ruan Jingzhou2,Lu Yuying2,Cheng Bang1,Wu Fang1,Wu Jinxia1,Liu Xuwen14,Song Fangming1,Chen Zhaoni1,Song Hui1,Liang Yonghong1,Guo Hongwei1

Affiliation:

1. Pharmaceutical College, Guangxi Medical University, Nanning, China

2. Guangxi Yuhualing Technology Development Co. LTD, Nanning, China

3. Life Sciences Institute, Guangxi Medical University, Nanning, China

4. Department of pharmacy, The People’s Hospital of Guangxi Zhuang autonomous region, Nanning, China

Abstract

Abstract Objectives Milletia speciosa Champ (MS), a traditional Chinese medicine, has the abilities of antistress, antifatigue, anti-oxidation and so on. In our previous study, MS was found to antidepression while the underlying mechanism of which needs further elucidation. Methods Here, a proton nuclear magnetic resonance (1H-NMR)-based metabonomics combined network pharmacology research approach was performed to investigate the antidepressive mechanism of MS act on mouse with chronic unpredictable mild stress-induced depression. Key findings Results showed that MS could alleviate the ethology of depression (including sucrose preference degree, crossing lattice numbers and stand-up times) and disordered biochemical parameters (5-hydroxytryptamine, norepinephrine and brain-derived neurotrophic factor). Metabonomics study and network pharmacology analysis showed that MS might improve depression through synergistically regulating five targets including Maoa, Maob, Ache, Ido1 and Comt, and three metabolic pathways such as tryptophan metabolism, synthesis of neurotransmitter and phospholipid metabolism. Conclusions This study for the first time preliminary clarified the potential antidepressive mechanism of MS and provided theoretical basis for developing MS into novel effective antidepressant.

Funder

Guangxi Natural Science Foundation

National Natural Science Foundation of China

Guangxi First class Discipline Project for Pharmaceutical Sciences

Scientific Research in Guangxi Higher Education Institutions

Youth Science Foundation of Guangxi Medical University

National Training Programs of Innovation and Entrepreneurship for Undergraduates of China

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3